- Home
- PXS vs CLNN Comparison
PXS vs CLNN Comparison
Compare PXS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- CLNN
- Stock Information
- Founded
- PXS 2015
- CLNN 2012
- Country
- PXS Greece
- CLNN United States
- Employees
- PXS N/A
- CLNN N/A
- Industry
- PXS Marine Transportation
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- PXS Consumer Discretionary
- CLNN Health Care
- Exchange
- PXS Nasdaq
- CLNN Nasdaq
- Market Cap
- PXS 44.0M
- CLNN 43.0M
- IPO Year
- PXS N/A
- CLNN N/A
- Fundamental
- Price
- PXS $3.94
- CLNN $4.79
- Analyst Decision
- PXS Strong Buy
- CLNN Strong Buy
- Analyst Count
- PXS 1
- CLNN 4
- Target Price
- PXS $10.00
- CLNN $55.25
- AVG Volume (30 Days)
- PXS 30.6K
- CLNN 69.0K
- Earning Date
- PXS 03-13-2025
- CLNN 03-12-2025
- Dividend Yield
- PXS N/A
- CLNN N/A
- EPS Growth
- PXS 63.38
- CLNN N/A
- EPS
- PXS 2.85
- CLNN N/A
- Revenue
- PXS $52,756,000.00
- CLNN $421,000.00
- Revenue This Year
- PXS $6.35
- CLNN N/A
- Revenue Next Year
- PXS $6.13
- CLNN N/A
- P/E Ratio
- PXS $1.38
- CLNN N/A
- Revenue Growth
- PXS 4.27
- CLNN N/A
- 52 Week Low
- PXS $3.41
- CLNN $3.82
- 52 Week High
- PXS $5.53
- CLNN $11.00
- Technical
- Relative Strength Index (RSI)
- PXS 53.14
- CLNN 46.32
- Support Level
- PXS $3.70
- CLNN $4.75
- Resistance Level
- PXS $4.40
- CLNN $5.06
- Average True Range (ATR)
- PXS 0.18
- CLNN 0.38
- MACD
- PXS 0.03
- CLNN -0.06
- Stochastic Oscillator
- PXS 43.90
- CLNN 2.60
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company that focuses on the product tanker sector. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Pyxis Epsilon, Pyxis Theta, Pyxis Malou, Northsea Alpha, and Northsea Beta. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).